These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7697635)

  • 1. Centromere spreading and centromeric aberrations in ovarian tumors.
    Zhu D; Ma MS; Zhao RZ; Li MY
    Cancer Genet Cytogenet; 1995 Mar; 80(1):63-5. PubMed ID: 7697635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic abnormalities in serous papillary adenocarcinoma of the ovary.
    Sahin I; Yilmaz Z; Sahin FI
    Eur J Gynaecol Oncol; 2004; 25(5):585-6. PubMed ID: 15493170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of chromosome 12 in human epithelial ovarian tumors: a chromosomal in situ hybridization study.
    Tanyi J; Tory K; Amo-Takyi BK; Füzesi L
    Int J Gynecol Pathol; 1998 Apr; 17(2):106-12. PubMed ID: 9553805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
    Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
    J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features.
    Pejovic T; Iosif CS; Mitelman F; Heim S
    Cancer Genet Cytogenet; 1996 Dec; 92(2):95-8. PubMed ID: 8976364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.
    Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ
    Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
    Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
    Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse tumorigenic pathways in ovarian serous carcinoma.
    Singer G; Kurman RJ; Chang HW; Cho SK; Shih IeM
    Am J Pathol; 2002 Apr; 160(4):1223-8. PubMed ID: 11943707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
    Afify AM; Werness BA; Mark HF
    Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of chromosome 6 in endometrial cancer.
    Tibiletti MG; Bernasconi B; Taborelli M; Furlan D; Fabbri A; Franchi M; Taramelli R; Trubia M; Capella C
    Br J Cancer; 1997; 75(12):1831-5. PubMed ID: 9192990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
    Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M
    Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
    Persons DL; Hartmann LC; Herath JF; Borell TJ; Cliby WA; Keeney GL; Jenkins RB
    Am J Pathol; 1993 Mar; 142(3):733-41. PubMed ID: 8096121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
    Kamiński K; Putowski L; Oleszczuk J
    Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
    Persons DL; Hartmann LC; Herath JF; Keeney GL; Jenkins RB
    Am J Clin Pathol; 1994 Dec; 102(6):775-9. PubMed ID: 7801890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early involvement of 6q in surface epithelial ovarian tumors.
    Tibiletti MG; Bernasconi B; Furlan D; Riva C; Trubia M; Buraggi G; Franchi M; Bolis P; Mariani A; Frigerio L; Capella C; Taramelli R
    Cancer Res; 1996 Oct; 56(19):4493-8. PubMed ID: 8813146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.
    Qu G; Dubeau L; Narayan A; Yu MC; Ehrlich M
    Mutat Res; 1999 Jan; 423(1-2):91-101. PubMed ID: 10029684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
    Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
    Genes Chromosomes Cancer; 1990 May; 2(1):48-52. PubMed ID: 2177641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.